Treatment success was measured as a change from baseline in the modified Friedreich’s Ataxia Rating Scale (mFARS) score. The mFARS is an assessment of neurological function and tests ...

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the process of definitive diagnosis through genetic testing, and the ...

Epidemiology, Pathophysiology, and Symptomatology of Friedreich Ataxia Video content above is prompted by the following: Describe the typical clinical presentation of FA in terms of age of onset ...

Friedreich’s ataxia is a progressive neuromuscular disease that causes uncoordinated movement, muscle weakness, balance problems, impaired speech, and frequently, heart abnormalities.

The beloved 'Science Guy' says many of his family members suffer from a rare neurological disorder that their ancestors had in colonial times Beloved "Science Guy" Bill Nye is sharing his family's ...

It is named for Nicholas Friedreich, a German pathologist who described the condition in the 1860s and 1870s.According to an article about Friedreich published in the Journal of Neurochemistry in 2013 ...

Correspondence to Dr Jose Luiz Pedroso, Division of General Neurology and Ataxia Unit, Department of Neurology, Universidade Federal de São Paulo - Campus São Paulo ...

Genetic analysis beyond the causative variants, and independent of the core clinical symptoms (pyramidal signs versus ataxia), might offer a more pertinent way to approach phenotypic variability.

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.